Self-reported responsiveness to direct-to-consumer drug advertising and medication use: Results of a national survey

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Dieringer, Nicholas J ^a   Kukkamma, Lisa ^b,c   Shorr, Ronald I ^a,b,d  

^a Methodist Healthcare ^*  (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Advertising; consumerism; medication use; non prescription medication; prescription medication

Indexed keywords

EID: 80053172491     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-232     Document Type: Article

References (20)

1. Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. Holmer AF, JAMA 1999 281 380 382 10.1001/jama.281.4.380 9929095 (Pubitemid 29061046)
2. Truth in Advertising: Rx Drug Ads Come of Age. Rados C, FDA Consum 2004 38 4 20 27 15595145
3. Direct-to-consumer prescription drug advertising: trends, impact, and implications. Wilkes MS, Bell RA, Kravitz RL, Health Aff (Millwood) 2000 19 110 128 10.1377/hlthaff.19.2.110
4. Promotion of prescription drugs to consumers. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM, N Engl J Med 2002 346 498 505 10.1056/NEJMsa012075 11844852 (Pubitemid 34441742)
5. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs-Summary of FDA Survey Research Results:Final Report. Aikin KJ, Swasy JL, Braman JC, US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research http://www.fda.gov/downloads/Drugs/ScienceResearch/ResearchAreas/ DrugMarketingAdvertisingandCommunicationsResearch/UCM152860.pdf Published November 19, 2004. Accessed August 7, 2011
6. A decade of direct-to-consumer advertising of prescription drugs. Donohue JM, Cevasco M, Rosenthal MB, N Engl J Med 2007 357 673 681 10.1056/NEJMsa070502 17699817 (Pubitemid 47267237)
7. DTC spending falls for second consecutive year Advertising Age. Thomaselli R, http://adage.com/article/news/dtc-spending-falls-consecutive-year/ 132499/ Published November 12, 2008. Accessed August 7, 2011
8. Prescription drugs: FDA oversight of direct-to-consumer advertising has limitations. (GAO-03-177). Washington, D.C.: United States General Accounting Office 2002
9. Direct-to-consumer prescription drug advertising and the public. Bell RA, Kravitz RL, Wilkes MS, J Gen Intern Med 1999 14 651 657 10.1046/j.1525-1497. 1999.01049.x 10571712
10. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Robinson AR, Hohmann KB, Rifkin JI, Topp D, Gilroy CM, Pickard JA, Anderson RJ, Arch Intern Med 2004 164 427 432 10.1001/archinte.164.4.427 14980994 (Pubitemid 38240707)
11. Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising. Henry J Kaiser Family Foundation http://www.kff.org/rxdrugs/3197- index.cfm. Published November 29, 2001. Accessed August 7, 2011
12. Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, Hinton L, Franks P, JAMA 2005 293 1995 2002 10.1001/jama.293.16.1995 15855433 (Pubitemid 40570893)
13. Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey. Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, Evans RG, Pan R, Marion SA, BMJ 2002 324 278 279 10.1136/bmj.324.7332.278 11823361 (Pubitemid 34121841)
14. Direct-to-consumer advertising: public perceptions of its effects on health behaviors, health care, and the doctor-patient relationship. Murray E, Lo B, Pollack L, Donelan K, Lee K, J Am Board Fam Pract 2004 17 6 18 10.3122/jabfm.17.1.6 15014047
15. Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Schommer JC, Singh RL, Hansen RA, Res Social Adm Pharm 2005 1 231 250 10.1016/j.sapharm.2005.03.009 17138476 (Pubitemid 44061727)
16. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies? Khanfar N, Loudon D, Sircar-Ramsewak F, Health Mark Q 2007 24 77 91 10.1080/07359680802125899 19042521
17. Physicians report on patient encounters involving direct-to-consumer advertising. Weissman JS, Blumenthal D, Silk AJ, Newman M, Zapert K, Leitman R, Feibelmann S, Health Aff (Millwood) 2004 Suppl Web Exclusives 4 33
18. Racial and ethnic disparities in response to direct-to-consumer advertising. Lee D, Begley CE, Am J Health Syst Pharm 2010 67 1185 1190 10.2146/ajhp090600 20592325
19. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG, Pharmacoepidemiol Drug Saf 2006 15 710 718 10.1002/pds.1226 16498575 (Pubitemid 44649509)
20. Congruence of self-reported medications with pharmacy prescription records in low-income older adults. Caskie GI, Willis SL, Gerontologist 2004 44 176 185 10.1093/geront/44.2.176 15075414 (Pubitemid 38541821)